A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy against Anemia of Chronic Disease

Hepcidin is the principal iron regulatory hormone, controlling the systemic absorption and remobilization of iron from intracellular stores. The expression of the hepcidin gene, HAMP, is increased in patients with anemia of chronic disease. Previously, the synthetic compound K7174 was identified through chemical screening as a novel inhibitor of the adhesion of monocytes to cytokine-stimulated endothelial cells. K7174 also ameliorated anemia induced by inflammatory cytokines in mice, which suggests a possible involvement of hepcidin regulation. The present study was performed to assess the impact of K7174 on hepcidin expression in a human hematoma cell line and in mice in vivo. We first demonstrated that K7174 treatment in HepG2 cells significantly decreased HAMP expression. Then, we conducted microarray analysis to determine the molecular mechanism by which K7174 inhibits HAMP expression. Transcriptional profiling confirmed the downregulation of HAMP. Surprisingly, we found that K7174 strongly induced GDF15, known as a negative regulator of HAMP expression. Western blotting analysis as well as ELISA confirmed the induction of GDF15 by K7174 treatment. Furthermore, K7174-mediated HAMP suppression was rescued by the silencing of GDF15 expression. Interestingly, we found that K7174 also upregulates CEBPB. Promoter analysis and chromatin immunoprecipitation analysis revealed that CEBPB could contribute to K7174-mediated transcriptional activation of GDF15. Subsequently, we also examined whether K7174 inhibits hepcidin expression in mice. Quantitative RT-PCR analysis with liver samples from K7174-treated mice demonstrated significant upregulation of Gdf15 and downregulation of Hamp expression, as compared to control mice. Furthermore, serum hepcidin concentration was also significantly decreased in K7174-treated mice. In conclusion, K7174 inhibits hepcidin expression partly by inducing GDF15. K-7174 may be a potential therapeutic option to treat anemia of chronic disease.

[1]  K. Finberg.  Regulation of systemic iron homeostasis , 2013, Current opinion in hematology.

[2]  K. Ishizawa,et al.  Role of transcriptional corepressor ETO2 in erythroid cells. , 2013, Experimental hematology.

[3]  Takashi Watanabe,et al.  Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells. , 2013, Biochemical and biophysical research communications.

[4]  E. Bresnick,et al.  Gene Expression Profiling Identifies HOXB4 as a Direct Downstream Target of GATA-2 in Human CD34+ Hematopoietic Cells , 2012, PloS one.

[5]  Elizabeta Nemeth,et al.  Hepcidin and iron homeostasis. , 2012, Biochimica et biophysica acta.

[6]  Herbert Y. Lin,et al.  Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation , 2012, American journal of hematology.

[7]  K. Hayashi,et al.  Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosis. , 2012, Blood cells, molecules & diseases.

[8]  C. Hong,et al.  Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. , 2011, Blood.

[9]  P. Brissot,et al.  GATA-4 transcription factor regulates hepatic hepcidin expression. , 2011, The Biochemical journal.

[10]  D. Scadden,et al.  Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. , 2011, Blood.

[11]  M. Somerfield,et al.  American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. , 2010, Blood.

[12]  H. Uno,et al.  Erythropoietic response and outcomes in kidney disease and type 2 diabetes. , 2010, The New England journal of medicine.

[13]  Seong-ho Lee,et al.  NSAID‐activated gene‐1 as a molecular target for capsaicin‐induced apoptosis through a novel molecular mechanism involving GSK3beta, C/EBPbeta, and ATF3 , 2010, Carcinogenesis.

[14]  S. Nakajima,et al.  ER stress depresses NF-kappaB activation in mesangial cells through preferential induction of C/EBP beta. , 2010, Journal of the American Society of Nephrology : JASN.

[15]  Henriette O'Geen,et al.  Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. , 2009, Molecular cell.

[16]  H. Tsukamoto,et al.  Hemojuvelin-Neogenin Interaction Is Required for Bone Morphogenic Protein-4-induced Hepcidin Expression* , 2009, The Journal of Biological Chemistry.

[17]  M. Kitamura,et al.  Unexpected blockade of adipocyte differentiation by K-7174: implication for endoplasmic reticulum stress. , 2007, Biochemical and biophysical research communications.

[18]  S. Goh,et al.  High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin , 2007, Nature Medicine.

[19]  M. Kitamura,et al.  Suppression of cytokine response by GATA inhibitor K-7174 via unfolded protein response. , 2007, Biochemical and biophysical research communications.

[20]  Yin Xia,et al.  Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. , 2007, The Journal of clinical investigation.

[21]  Raymond T Chung,et al.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.

[22]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[23]  T. Kodama,et al.  Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease. , 2004, Blood.

[24]  N. Andrews.  Anemia of inflammation: the cytokine-hepcidin link. , 2004, The Journal of clinical investigation.

[25]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[26]  T. Kodama,et al.  A GATA‐specific inhibitor (K‐7174) rescues anemia induced by IL‐1β, TNF‐α, or l‐NMMA , 2003 .

[27]  Tomas Ganz,et al.  Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. , 2003, Blood.

[28]  T. Kodama,et al.  A novel cell adhesion inhibitor, K-7174, reduces the endothelial VCAM-1 induction by inflammatory cytokines, acting through the regulation of GATA. , 2000, Biochemical and biophysical research communications.

[29]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.